Diabetes drugs face off in major heart failure study
NCT ID NCT06980623
Summary
This study compares two diabetes medications, tirzepatide and semaglutide, to see which works better at preventing heart failure hospitalizations and death in people who have both type 2 diabetes and a specific type of heart failure. Researchers will follow 26,000 patients using real-world insurance data to track their health outcomes. The goal is to help doctors choose the best medication for patients with these two common conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
Conditions
Explore the condition pages connected to this study.